Insights into brigatinib’s rare side effects may help more lung cancer patients benefit from the drug

“This side effect can disappear within days despite continued exposure to the drug,” says D. Ross Camidge, MD, PhD.

CU’s Sarcoma Multidisciplinary Clinic: 20 rare cancer experts in one room

20 experts provide each patient with a personalized plan to treat their sarcoma

The genetic diversity that may explain differences in cancer rates across ethnicities

Differences in HLA proteins across ethnicities could help to explain the differences in cancer rates between human cultures.

Latest News from the University of Colorado Cancer Center

2019 Olink Proteomics Pilot Award

Genomics and Microarray CoreCall for Proposals | 2019 Olink Proteomics Pilot Award Revlevant Dates:Application Deadline                     5-24-2019Award Announcement            ...

read more

@CUCancerCenter on Twitter